Nevia Bio vs Nucleix

Nevia Bio vs Nucleix, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nevia Bio is on 53/100 and Nucleix on 56/100.

Nevia Bio logo
Nevia BioNevia Bio is a femtech startup focused on early detection of women's health conditions.
Try Nevia Bio
Nucleix logo
NucleixNucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
Try Nucleix

Where each one leads

Nevia Bio

  • agent readiness: 51/100 against 30/100

Nucleix

  • our overall score: 56/100 against 53/100
  • domain rating: 38/100 against 7/100
  • headcount: 74 against 13
  • funding raised: $88.0M against $5.5M
  • LinkedIn following: 7,846 against 1,652

At a glance

MeasureNevia BioNucleix
What it isNevia Bio is a femtech startup focused on early detection of women's health conditions.Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
CategoryHealthcare, FemTech, HealthTech, MedTechHealthcare, Lung, Bladder, Cancer
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20152008
HeadquartersTel Aviv, IsraelRehovot, Israel
StatusInactiveActive

Size, funding and growth

MeasureNevia BioNucleix
Employees1374
Headcount growthLast 12 monthsNot published+7.1%
Total funding$5.5M$88.0M
Latest roundSeedFunding Round
LinkedIn followers1,6527,846

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureNevia BioNucleix
StartupHub scoreOur 0-100 rating53/10056/100
Traction45/10059/100
Team60/10070/100
Community8/100Not published
Search visibility35/10036/100
Quality58/10055/100
Agent readinessHow well an AI agent can read and act on the siteD (51/100)F (30/100)
Domain ratingLink authority, 0-1007/10038/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureNevia BioNucleix
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4

What users say

MeasureNevia BioNucleix
Reddit sentimentThreads we trackNot published6 positive, 0 negative across 6 threads
Nucleix
Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.
r/LungCancerSupport

Nevia Bio vs Nucleix: common questions

Which is better, Nevia Bio or Nucleix?

On our 0-100 score Nucleix rates higher (56/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Nevia Bio and Nucleix compare on the numbers?

Nevia Bio leads on agent readiness (51/100 against 30/100). Nucleix leads on our overall score (56/100 against 53/100), domain rating (38/100 against 7/100), headcount (74 against 13), funding raised ($88.0M against $5.5M), LinkedIn following (7,846 against 1,652).

What do real users say about Nevia Bio and Nucleix?

Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.

Read the full Nevia Bio review and pricing or the Nucleix review and pricing. You can also browse other Nevia Bio alternatives we track.